Collectively, high-dose ALA suppresses ferritinophagy and activates the SLC7A11/GSH/GPX4 antioxidant axis via the AMPK-STAT3 signaling pathway to alleviate ferroptosis-induced diabetic cardiomyopathy. This evidence concerns the gene GPX4 and diabetic cardiomyopathy.